Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03611764
Other study ID # 201803060
Secondary ID
Status Terminated
Phase Phase 1
First received
Last updated
Start date April 17, 2018
Est. completion date August 28, 2018

Study information

Verified date October 2018
Source Washington University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will address whether teaching the Body Scan exercise to cancer patients with hematological malignancies and their caregivers during an inpatient hospitalization improves reported physical and psychological symptoms after a two-week period. Giving patients and caregivers the opportunity to learn mindfulness and the tools to practice on their own is expected to lead to a decrease in stress and anxiety, and help empower patients and caregivers to better cope with stress in the future.


Recruitment information / eligibility

Status Terminated
Enrollment 37
Est. completion date August 28, 2018
Est. primary completion date August 28, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Voluntary & self-selected patients and caregivers

- Located on the leukemia/lymphoma/bone marrow transplant floor at Barnes Jewish Hospital

Exclusion Criteria:

-Patients requiring a language translator or interpreter will be excluded from the study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Body Scan
-All efforts will be made to normalize their experience: for example, the desire to open their eyes, thinking about other things, wanting to move around - these are all normal and participants will be encouraged to become interested in and curious about, and to allow these natural tendencies
Other:
Rotterdam Symptom Checklist
39 Likert-scale items, including physical and psychological symptoms (30 questions), daily function (8 questions), and overall valuation of life (one question) For the 30 questions pertaining to symptoms, the four-item Likert scale ranges from 'not at all=1' to 'very much=4'; the higher the total score, the greater the score, the higher the level of distress. The single question pertaining to overall valuation of life asks participants to circle one of the seven items, ranked from "extremely poor" to "excellent"
Practice Logs
-Describe frequency of the Zen Den

Locations

Country Name City State
United States Washington University School of Medicine Saint Louis Missouri

Sponsors (2)

Lead Sponsor Collaborator
Washington University School of Medicine Barnes-Jewish Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measure of distress in patients measured by the RSCL scores -Inferential statistics will be used to analyze the Rotterdam Symptom Checklist (RSCL) Through 2 weeks
Primary Measure of distress in caregivers measured by the RSCL scores -Inferential statistics will be used to analyze the Rotterdam Symptom Checklist (RSCL) Through 2 weeks
Secondary Frequency of body scan practice -Practice Logs will be used to notate frequency of body scan practice Through 2 weeks
See also
  Status Clinical Trial Phase
Completed NCT04932967 - Use of nMoABs for the Treatment of COVID-19 in Patients With HM.
Not yet recruiting NCT02900768 - Effects of Exercise on Allogeneic Stem Cell Transplant N/A
Recruiting NCT04082910 - Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells Phase 1/Phase 2
Recruiting NCT05510089 - Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies N/A
Terminated NCT04093622 - Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy
Recruiting NCT06225856 - An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies Phase 1
Recruiting NCT06106360 - A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy
Recruiting NCT02828462 - Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics
Completed NCT01714180 - Effect of Body Mass on Acyclovir Pharmacokinetics N/A
Completed NCT03241550 - A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients Phase 1
Active, not recruiting NCT04684108 - SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies Phase 1
Completed NCT02598752 - Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
Completed NCT02880709 - The Effect of Special Diets in Hematological Cancer Patients Phase 4
Completed NCT00894049 - A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation Phase 2
Completed NCT04687982 - Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002). N/A
Completed NCT00897260 - Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders N/A
Recruiting NCT03850366 - HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib Phase 2
Not yet recruiting NCT06066255 - PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM Phase 2
Enrolling by invitation NCT05364359 - Individual Dietary Counseling Based on Taste-tests in Patients With Hematological Cancer in Cytostatic Therapy N/A
Recruiting NCT04841447 - Membrane Target Detection for Leukemia Treatment